1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Patrick Stiff: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS Vidaza and Valproic Acid - Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS | Phase 2 | Unknown | Patrick Stiff | 50 | 2012-01-01 | 2021-04-26 |
Anemia, Refractory, with Excess of Blasts (1) · Leukemia, Myeloid, Acute (1) · Myelodysplastic Syndromes (1)
Azacitidine (1) · Valproic Acid (1)
United States (1)